Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03213665
Brief Title: Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

First Submitted : July 10, 2017
First Submitted that Met QC Criteria : July 10, 2017
First Posted : July 11, 2017

Last Update Submitted that Met QC Criteria : November 5, 2019
Last Update Posted : November 6, 2019